Entry | Author | Date | Location | |
---|---|---|---|---|
Endocyte Cuts Workforce by 40 Percent After Clinical Trial Falters | Frank Vinluan | 06/02/17 | Indiana | |
Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More | Ben Fidler | 06/24/16 | National | |
EndoCyte’s Ellis Out as CEO, Sherman Appointed to Top Spot | Frank Vinluan | 06/20/16 | Indiana | |
Page 1 of 1 | ||||